Skip to main content

Table 5 NPC mortality in China in 2013

From: Nasopharyngeal carcinoma incidence and mortality in China, 2013

Areas

Sex

CR (1/105)

Prop (%)

ASMRC (1/105)

ASMRW (1/105)

Cum rate (%)

TASR (1/105)

Rank

All

Both

1.57

0.96

1.10

1.08

0.12

2.09

18

Male

2.26

1.12

1.63

1.60

0.19

3.10

13

Female

0.84

0.68

0.58

0.56

0.06

1.06

18

Urban areas

Both

1.61

1.00

1.09

1.07

0.12

2.10

19

Male

2.38

1.21

1.65

1.62

0.19

3.16

14

Female

0.81

0.65

0.54

0.52

0.06

1.01

19

Rural areas

Both

1.51

0.91

1.12

1.09

0.13

2.08

18

Male

2.12

1.02

1.62

1.58

0.18

3.02

12

Female

0.87

0.71

0.63

0.61

0.07

2.13

16

Eastern areas

Both

1.62

0.86

1.02

1.00

0.12

3.27

17

Male

2.35

1.01

1.51

1.49

0.18

0.95

13

Female

0.87

0.61

0.53

0.52

0.06

2.02

18

Middle areas

Both

1.41

0.91

1.06

1.03

0.11

2.98

19

Male

2.05

1.06

1.59

1.55

0.17

1.03

13

Female

0.75

0.64

0.54

0.53

0.06

3.21

18

Western areas

Both

2.15

1.38

1.63

1.59

0.18

4.82

15

Male

3.07

1.54

2.36

2.29

0.27

1.55

10

Female

1.20

1.07

0.91

0.89

0.10

2.13

15

  1. CR crude rate, Prop proportion, ASMRC age-standardized mortality rate by Chinese standard population, ASMRW, age-standardized mortality rate by 1985 Segi’s world standard population, Cum rate cumulative rate for patients aged 0–74 years, TASR truncated age-standardized rate for patients aged 35–64 years, Rank rank of NPC mortality in all cancers’ mortalities